» Articles » PMID: 16631415

Health Care Resource Utilization in Inflammatory Bowel Disease

Overview
Specialty Gastroenterology
Date 2006 Apr 25
PMID 16631415
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: The aim of this study was to quantify temporal changes in health care utilization by a population-based cohort of IBD.

Methods: By using the University of Manitoba IBD Epidemiology Database we assessed utilization of outpatient and hospital services, estimating relative risk (RR) of utilization for IBD cases compared with a matched cohort of non-IBD controls and for CD versus UC. We tested differences in utilization between prevalence cohorts 1990-1991 and 2000-2001. Also, utilization of the 1987-1988 incidence cohort was followed forward 15 years from diagnosis. The probability, intensity, and volume of utilization were estimated.

Results: In 2000-2001, IBD patients compared with controls were more likely to have an outpatient visit (RR, 1.18; 95% confidence interval [CI], 1.17-1.19) and an overnight hospital stay (RR, 2.32; 95% CI, 2.16-2.49). CD cases were more likely than UC cases to be hospitalized (RR, 1.26; 95% CI, 1.11-1.43) and had a greater number of outpatient visits. From 1990-1991 to 2000-2001, IBD cases experienced a significant decrease in the likelihood of an outpatient surgical visit relative to non-IBD controls (P < .05), and for those cases who were hospitalized, CD cases tended to be less likely than UC cases to experience IBD-specific inpatient surgery (P < .07). Of the 1987-1988 incidence cohort, 80% of admissions that occurred during the follow-up period were during the first 5 years after diagnosis.

Conclusions: In 2000-2001, health care utilization continued to be higher in IBD versus controls and CD versus UC; however, the gap in costly service utilization appeared to narrow between the latter pair.

Citing Articles

Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease.

Zhen J, Simoneau M, Sharma P, Germain P, Watier-Levesque P, Othman A J Can Assoc Gastroenterol. 2024; 7(6):423-430.

PMID: 39679104 PMC: 11638002. DOI: 10.1093/jcag/gwae029.


Racial and Ethnic Disparities in Inflammatory Bowel Disease.

Borum M Gastroenterol Hepatol (N Y). 2023; 19(5):281-283.

PMID: 37799459 PMC: 10548245.


Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland.

Markiewicz-Loskot G, Chlebowczyk W, Holecki T Children (Basel). 2023; 10(7).

PMID: 37508609 PMC: 10378369. DOI: 10.3390/children10071112.


Systematic Review of Self-Management Assessment Tools for Children With Inflammatory Bowel Disease.

Vernon-Roberts A, Rouse E, Gearry R, Day A JPGN Rep. 2023; 2(3):e075.

PMID: 37205965 PMC: 10191491. DOI: 10.1097/PG9.0000000000000075.


Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease.

Zhen J, Marshall J, Nguyen G, Atreja A, Narula N J Med Syst. 2021; 45(2):23.

PMID: 33449213 PMC: 7808932. DOI: 10.1007/s10916-021-01706-x.